Dual-targeted Contrast Agent for US Assessment of Tumor Angiogenesis in Vivo
Top Cited Papers
- 1 September 2008
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 248 (3) , 936-944
- https://doi.org/10.1148/radiol.2483072231
Abstract
The results of our study suggest that dual-targeted contrast-enhanced US targeting both vascular endothelial growth factor receptor 2 and αvβ3 integrin improves in vivo visualization of tumor angio... PurposeTo develop and validate a dual-targeted ultrasonographic (US) imaging agent with microbubbles (MBs) that attaches to both vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) and αv...This publication has 23 references indexed in Scilit:
- Targeted Microbubbles for Imaging Tumor Angiogenesis: Assessment of Whole-Body Biodistribution with Dynamic Micro-PET in MiceRadiology, 2008
- US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in MiceRadiology, 2008
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic SwitchCell Cycle, 2006
- Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor PerfusionClinical Cancer Research, 2005
- Endogenous Inhibitors of AngiogenesisCancer Research, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3Circulation, 2003
- The Hallmarks of CancerCell, 2000
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971